Drug Hunter Flash Talks

​The Drug Hunter Speaker Series is an ongoing series of talks about drug discovery with the Drug Hunter team and guest experts in the field. ​​Each virtual event has a presentation, interview, or conversation with guests, followed by audience Q&A and discussion.

REGISTER FOR THE SERIES

​You can watch previous sessions on our Drug Hunter YouTube channel, and see examples of past speakers and topics below.

The Discovery of PAXLOVID
Dafydd Owen
08/31/23
From "Just Another Kinase" to a new Treatment for Myelofibrosis
Andrew Wilks
TALK RECORDED ON 01/25/23
Analysis of Successful Hit-to-Clinical Candidate Pairs
Dean Brown, Ph.D.
TALK RECORDED ON 04/18/24
Drug Discovery Strategies to Optimize Unbound Brain Concentrations in CNS Infectious Diseases with Dennis Koester
Dennis Koester
TALK RECORDED ON 12/08/22
Strategies to Extend Duration of Action for Oral and Inhaled Drugs
Christian Gampe , Ph.D.
TALK RECORDED ON 08/17/22
Protein Aggregation and the Development of NU-9 (also known as AKV9) for Upper Motor Neuron Diseases, Including ALS
Prof. Hande Ozdinler, Ph.D.
TALK RECORDED ON 08/30/22
Protein Aggregation and the Development of NU-9 (also known as AKV9) for Upper Motor Neuron Diseases, Including ALS
Prof. Richard B. Silverman, Ph.D.
TALK RECORDED ON 08/30/22
A Med Chemist's Guide to Formulation Options to Improve Oral Bioavailability
Tamas Solymosi, Ph.D.
TALK RECORDED ON 12/12/23
How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments
Oliver Philps
TALK RECORDED ON 03/14/24
Not Your Grandparents' Drugs: How Drugs Changed Since the 70's... and What to Do About It
Christian Jones
TALK RECORDED ON 05/10/23
Visible Light Photoredox Chemistry at Commercial Scale
Kaid Harper
TALK RECORDED ON 02/21/23
From "Just Another Kinase" to a new Treatment for Myelofibrosis
Chris Burns
TALK RECORDED ON 01/25/23
Meet the Founder and CEO of a Billion-Dollar CDMO, Oliver Ju
Oliver Ju
TALK RECORDED ON 12/01/22
Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor
Andrew Parsons
TALK RECORDED ON 04/19/23
The discovery and characterization of CFT8634: A potent and selective degrader of BRD9 for the treatment of SMARCB1 perturbed cancer
Kate Jackson
06/29/22

upcoming Drug Hunter Events

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >8,000 drug hunters worldwide. Unsubscribe anytime.

VIEW MORE CONTENT
VIEW MORE RESOURCES